Cardiac allograft vasculopathy after heart transplantation: Is it really ominous?

Ju Yong LimSung Ho JungMin Seok KimJeong-Jun ParkTae-Jin YunJae Joong KimJae Won Lee

Published in: Clinical transplantation (2017)

CAV incidence after HT appears acceptable, with most cases being stationary and inconsequential for survival. Development of CAV seems to be influenced by donor and recipient age, ischemic time, postoperative RRT, and high triglyceride level.

Keyphrases

patients undergoing
risk factors
left ventricular
liquid chromatography
ischemia reperfusion injury
free survival
kidney transplantation
heart failure
cerebral ischemia
mass spectrometry
brain injury
low density lipoprotein
atrial fibrillation